JPS6129355B2 - - Google Patents
Info
- Publication number
- JPS6129355B2 JPS6129355B2 JP51156110A JP15611076A JPS6129355B2 JP S6129355 B2 JPS6129355 B2 JP S6129355B2 JP 51156110 A JP51156110 A JP 51156110A JP 15611076 A JP15611076 A JP 15611076A JP S6129355 B2 JPS6129355 B2 JP S6129355B2
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidone
- pyridylmethyl
- methyl
- ethylamino
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 82
- 150000001875 compounds Chemical class 0.000 claims description 68
- 229960001340 histamine Drugs 0.000 claims description 41
- -1 4-imidazolyl ring Chemical group 0.000 claims description 40
- 150000003839 salts Chemical class 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims description 8
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 6
- 239000011593 sulfur Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 125000004354 sulfur functional group Chemical group 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical compound OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 claims description 3
- SXPQTJIXPDUPFC-UHFFFAOYSA-N 2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-2-ylmethyl)-1h-pyrimidin-6-one Chemical compound BrC1=CC=CN=C1CSCCNC(NC1=O)=NC=C1CC1=CC=CC=N1 SXPQTJIXPDUPFC-UHFFFAOYSA-N 0.000 claims description 2
- ZOUZZCWWNKSAQM-UHFFFAOYSA-N 2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound BrC1=CC=CN=C1CSCCNC(NC1=O)=NC=C1CC1=CC=CN=C1 ZOUZZCWWNKSAQM-UHFFFAOYSA-N 0.000 claims description 2
- MHYLRSCNIOCCDP-UHFFFAOYSA-N 2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-4-ylmethyl)-1h-pyrimidin-6-one Chemical compound BrC1=CC=CN=C1CSCCNC(NC1=O)=NC=C1CC1=CC=NC=C1 MHYLRSCNIOCCDP-UHFFFAOYSA-N 0.000 claims description 2
- PTAVKDQBVPYPPR-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(1,3-thiazol-2-ylmethyl)-1h-pyrimidin-6-one Chemical compound N1C=NC(CSCCNC=2NC(=O)C(CC=3SC=CN=3)=CN=2)=C1C PTAVKDQBVPYPPR-UHFFFAOYSA-N 0.000 claims description 2
- OILOSGYWCWVWIW-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(pyridin-2-ylmethyl)-1h-pyrimidin-6-one Chemical compound N1C=NC(CSCCNC=2NC(=O)C(CC=3N=CC=CC=3)=CN=2)=C1C OILOSGYWCWVWIW-UHFFFAOYSA-N 0.000 claims description 2
- CORCSBUUHIYAOL-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound N1C=NC(CSCCNC=2NC(=O)C(CC=3C=NC=CC=3)=CN=2)=C1C CORCSBUUHIYAOL-UHFFFAOYSA-N 0.000 claims description 2
- VMAIGCRCCIHHFC-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(pyridin-4-ylmethyl)-1h-pyrimidin-6-one Chemical compound N1C=NC(CSCCNC=2NC(=O)C(CC=3C=CN=CC=3)=CN=2)=C1C VMAIGCRCCIHHFC-UHFFFAOYSA-N 0.000 claims description 2
- BTOWXISBYWBZAB-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(thiophen-2-ylmethyl)-1h-pyrimidin-6-one Chemical compound N1C=NC(CSCCNC=2NC(=O)C(CC=3SC=CC=3)=CN=2)=C1C BTOWXISBYWBZAB-UHFFFAOYSA-N 0.000 claims description 2
- XQCZBXHVTFVIFE-UHFFFAOYSA-N 2-amino-4-hydroxypyrimidine Chemical compound NC1=NC=CC(O)=N1 XQCZBXHVTFVIFE-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- RMAKEAAKXDXYMQ-UHFFFAOYSA-N 5-(pyridin-4-ylmethyl)-2-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethylamino]-1h-pyrimidin-6-one Chemical compound N=1C=C(CC=2C=CN=CC=2)C(=O)NC=1NCCSCC1=NC=CS1 RMAKEAAKXDXYMQ-UHFFFAOYSA-N 0.000 claims 1
- 230000008485 antagonism Effects 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 117
- 238000002844 melting Methods 0.000 description 75
- 230000008018 melting Effects 0.000 description 75
- 239000000203 mixture Substances 0.000 description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 50
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 40
- 230000001746 atrial effect Effects 0.000 description 39
- 210000003405 ileum Anatomy 0.000 description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- 238000000034 method Methods 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- 239000007787 solid Substances 0.000 description 13
- 239000000460 chlorine Substances 0.000 description 12
- 238000000921 elemental analysis Methods 0.000 description 12
- 229960000583 acetic acid Drugs 0.000 description 11
- JEOZNMMOIBLWLV-UHFFFAOYSA-N 2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethanamine Chemical compound CC=1N=CNC=1CSCCN JEOZNMMOIBLWLV-UHFFFAOYSA-N 0.000 description 10
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 9
- 239000008240 homogeneous mixture Substances 0.000 description 9
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 9
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- WAIHMWWSWLOHNH-UHFFFAOYSA-N 2-(1,3-thiazol-2-ylmethylsulfanyl)ethanamine Chemical compound NCCSCC1=NC=CS1 WAIHMWWSWLOHNH-UHFFFAOYSA-N 0.000 description 7
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 7
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 7
- 230000004071 biological effect Effects 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000001632 sodium acetate Substances 0.000 description 6
- 235000017281 sodium acetate Nutrition 0.000 description 6
- 239000012258 stirred mixture Substances 0.000 description 6
- VMQFULFMPBMJID-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(1,3-thiazol-2-ylmethyl)-1h-pyrimidin-6-one;trihydrochloride Chemical compound Cl.Cl.Cl.N1C=NC(CSCCNC=2NC(=O)C(CC=3SC=CN=3)=CN=2)=C1C VMQFULFMPBMJID-UHFFFAOYSA-N 0.000 description 5
- OKERYJZDTINJGP-UHFFFAOYSA-N 4-(3-chloropyridin-2-yl)butan-1-amine Chemical compound NCCCCC1=NC=CC=C1Cl OKERYJZDTINJGP-UHFFFAOYSA-N 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 description 4
- UMCHIQCDVOOJLO-UHFFFAOYSA-N 2-[(3-bromopyridin-2-yl)methylsulfanyl]ethanamine Chemical compound NCCSCC1=NC=CC=C1Br UMCHIQCDVOOJLO-UHFFFAOYSA-N 0.000 description 4
- XFZLAEXVWQCHMU-UHFFFAOYSA-N 4-(5-methyl-1h-imidazol-4-yl)butan-1-amine Chemical compound CC=1NC=NC=1CCCCN XFZLAEXVWQCHMU-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000005557 antagonist Substances 0.000 description 4
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 4
- 239000002026 chloroform extract Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- 229960000582 mepyramine Drugs 0.000 description 4
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 4
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 238000001665 trituration Methods 0.000 description 4
- PBMMIUUMAXTAJD-UHFFFAOYSA-N 2-[(3-fluoropyridin-2-yl)methylsulfanyl]ethanamine Chemical compound NCCSCC1=NC=CC=C1F PBMMIUUMAXTAJD-UHFFFAOYSA-N 0.000 description 3
- KZRZMQRVMQVELJ-UHFFFAOYSA-N 2-methylsulfanyl-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=CN=C1 KZRZMQRVMQVELJ-UHFFFAOYSA-N 0.000 description 3
- CDXLMOHXDMHKOQ-UHFFFAOYSA-N 2-methylsulfanyl-5-(pyridin-4-ylmethyl)-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=NC=C1 CDXLMOHXDMHKOQ-UHFFFAOYSA-N 0.000 description 3
- XMLZZXNLTIVKDH-UHFFFAOYSA-N 4-(3-methoxypyridin-2-yl)butan-1-amine Chemical compound COC1=CC=CN=C1CCCCN XMLZZXNLTIVKDH-UHFFFAOYSA-N 0.000 description 3
- VQVVSGJUYKOPQT-UHFFFAOYSA-N 6-methyl-2-methylsulfanyl-5-(pyridin-3-ylmethyl)-1h-pyrimidin-4-one Chemical compound O=C1NC(SC)=NC(C)=C1CC1=CC=CN=C1 VQVVSGJUYKOPQT-UHFFFAOYSA-N 0.000 description 3
- UJTTUOLQLCQZEA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(4-hydroxybutyl)carbamate Chemical compound C1=CC=C2C(COC(=O)NCCCCO)C3=CC=CC=C3C2=C1 UJTTUOLQLCQZEA-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 230000027119 gastric acid secretion Effects 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 210000002837 heart atrium Anatomy 0.000 description 3
- 239000000938 histamine H1 antagonist Substances 0.000 description 3
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- ZNEYACZYGQIIBD-UHFFFAOYSA-N 2-(4-aminobutyl)pyridin-3-amine Chemical compound NCCCCC1=NC=CC=C1N ZNEYACZYGQIIBD-UHFFFAOYSA-N 0.000 description 2
- ROQJWJJTTQDQJY-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one;trihydrochloride Chemical compound Cl.Cl.Cl.N1C=NC(CSCCNC=2NC(=O)C(CC=3C=NC=CC=3)=CN=2)=C1C ROQJWJJTTQDQJY-UHFFFAOYSA-N 0.000 description 2
- ZEJHNAWMJMJMCZ-UHFFFAOYSA-N 2-chloro-5,6-dimethylpyridine-3-carbaldehyde Chemical compound CC1=CC(C=O)=C(Cl)N=C1C ZEJHNAWMJMJMCZ-UHFFFAOYSA-N 0.000 description 2
- VOCKNCWQVHJMAE-UHFFFAOYSA-N 2-methoxypyridine-4-carbaldehyde Chemical compound COC1=CC(C=O)=CC=N1 VOCKNCWQVHJMAE-UHFFFAOYSA-N 0.000 description 2
- NZAZWLSRKMDRNS-UHFFFAOYSA-N 2-methoxypyridine-4-carbonitrile Chemical compound COC1=CC(C#N)=CC=N1 NZAZWLSRKMDRNS-UHFFFAOYSA-N 0.000 description 2
- DADQIFJRAOADQS-UHFFFAOYSA-N 2-methylsulfanyl-5-(pyridin-2-ylmethyl)-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=CC=N1 DADQIFJRAOADQS-UHFFFAOYSA-N 0.000 description 2
- ACEZBZGYTQQHLL-UHFFFAOYSA-N 2-methylsulfanyl-5-(thiophen-2-ylmethyl)-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=CS1 ACEZBZGYTQQHLL-UHFFFAOYSA-N 0.000 description 2
- JKLLJHVEAMNKJV-UHFFFAOYSA-N 2-sulfanylidene-5-(thiophen-2-ylmethyl)-1h-pyrimidin-4-one Chemical compound O=C1NC(=S)NC=C1CC1=CC=CS1 JKLLJHVEAMNKJV-UHFFFAOYSA-N 0.000 description 2
- FZLICDPECGYZOF-UHFFFAOYSA-N 4-(3-ethoxypyridin-2-yl)butan-1-amine Chemical compound CCOC1=CC=CN=C1CCCCN FZLICDPECGYZOF-UHFFFAOYSA-N 0.000 description 2
- STIOUOHCWDHSJY-UHFFFAOYSA-N 4-pyridin-2-ylbutan-1-amine Chemical compound NCCCCC1=CC=CC=N1 STIOUOHCWDHSJY-UHFFFAOYSA-N 0.000 description 2
- KWONOCUDBWGFMH-UHFFFAOYSA-N 4-pyridin-2-ylbutanenitrile Chemical compound N#CCCCC1=CC=CC=N1 KWONOCUDBWGFMH-UHFFFAOYSA-N 0.000 description 2
- ZGQMZSLCKZISPS-UHFFFAOYSA-N 5-(pyridin-2-ylmethyl)-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound O=C1NC(=S)NC=C1CC1=CC=CC=N1 ZGQMZSLCKZISPS-UHFFFAOYSA-N 0.000 description 2
- CUIGMTBOVADTRB-UHFFFAOYSA-N 5-(pyridin-3-ylmethyl)-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound O=C1NC(=S)NC=C1CC1=CC=CN=C1 CUIGMTBOVADTRB-UHFFFAOYSA-N 0.000 description 2
- QIPGVGIOHUZFGO-UHFFFAOYSA-N 5-(quinolin-3-ylmethyl)-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound O=C1NC(=S)NC=C1CC1=CN=C(C=CC=C2)C2=C1 QIPGVGIOHUZFGO-UHFFFAOYSA-N 0.000 description 2
- CTAIEPPAOULMFY-UHFFFAOYSA-N 6-methoxypyridine-3-carbaldehyde Chemical compound COC1=CC=C(C=O)C=N1 CTAIEPPAOULMFY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- FKCBLVCOSCZFHV-UHFFFAOYSA-N acetonitrile;ethanol Chemical compound CCO.CC#N FKCBLVCOSCZFHV-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 2
- 229960003291 chlorphenamine Drugs 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 229960000520 diphenhydramine Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- MJQIKGNOUNINSS-UHFFFAOYSA-N ethyl 3-(1,3-thiazol-2-yl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=NC=CS1 MJQIKGNOUNINSS-UHFFFAOYSA-N 0.000 description 2
- FDUJSLFRGSYDGZ-UHFFFAOYSA-N ethyl 3-(1,3-thiazol-2-yl)propanoate Chemical compound CCOC(=O)CCC1=NC=CS1 FDUJSLFRGSYDGZ-UHFFFAOYSA-N 0.000 description 2
- QYWJJYWOBGZKHP-UHFFFAOYSA-N ethyl 3-(6-methoxypyridin-3-yl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(OC)N=C1 QYWJJYWOBGZKHP-UHFFFAOYSA-N 0.000 description 2
- ZABMIGDVOIATQB-UHFFFAOYSA-N ethyl 3-(6-methylpyridin-3-yl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(C)N=C1 ZABMIGDVOIATQB-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- RAIYODFGMLZUDF-UHFFFAOYSA-N piperidin-1-ium;acetate Chemical compound CC([O-])=O.C1CC[NH2+]CC1 RAIYODFGMLZUDF-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- MTYDTSHOQKECQS-UHFFFAOYSA-N (4-methylpyridin-2-yl)methanol Chemical compound CC1=CC=NC(CO)=C1 MTYDTSHOQKECQS-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- GBBZLMLLFVFKJM-UHFFFAOYSA-N 1,2-diiodoethane Chemical compound ICCI GBBZLMLLFVFKJM-UHFFFAOYSA-N 0.000 description 1
- VLXSIHLNPYRFFN-UHFFFAOYSA-N 1,4-dioxane;methanol Chemical compound OC.C1COCCO1 VLXSIHLNPYRFFN-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- HDQQOCDJJDAEPU-UHFFFAOYSA-N 2-(6-methylpyridin-3-yl)prop-2-enoic acid Chemical compound CC1=CC=C(C=N1)C(C(=O)O)=C HDQQOCDJJDAEPU-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HTABEAIBEITBJS-UHFFFAOYSA-N 2-[(3-chloropyridin-2-yl)methylsulfanyl]ethanamine Chemical compound NCCSCC1=NC=CC=C1Cl HTABEAIBEITBJS-UHFFFAOYSA-N 0.000 description 1
- SKTYIFIVFLNTCA-UHFFFAOYSA-N 2-[(3-iodopyridin-2-yl)methylsulfanyl]ethanamine Chemical compound NCCSCC1=NC=CC=C1I SKTYIFIVFLNTCA-UHFFFAOYSA-N 0.000 description 1
- VGMZAKKUIGITCD-UHFFFAOYSA-N 2-[(3-methoxypyridin-2-yl)methylsulfanyl]ethanamine Chemical compound COC1=CC=CN=C1CSCCN VGMZAKKUIGITCD-UHFFFAOYSA-N 0.000 description 1
- SDTBFMITSFWSSR-UHFFFAOYSA-N 2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-2-ylmethyl)-1h-pyrimidin-6-one;trihydrobromide Chemical compound Br.Br.Br.BrC1=CC=CN=C1CSCCNC(NC1=O)=NC=C1CC1=CC=CC=N1 SDTBFMITSFWSSR-UHFFFAOYSA-N 0.000 description 1
- FANONQPHTHZJOA-UHFFFAOYSA-N 2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one;trihydrobromide Chemical compound Br.Br.Br.BrC1=CC=CN=C1CSCCNC(NC1=O)=NC=C1CC1=CC=CN=C1 FANONQPHTHZJOA-UHFFFAOYSA-N 0.000 description 1
- OYDQNYJYOOQUDY-UHFFFAOYSA-N 2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-4-ylmethyl)-1H-pyrimidin-6-one dihydrochloride Chemical compound Cl.Cl.BrC1=CC=CN=C1CSCCNC(NC1=O)=NC=C1CC1=CC=NC=C1 OYDQNYJYOOQUDY-UHFFFAOYSA-N 0.000 description 1
- NYDBUAOXTSYPNN-UHFFFAOYSA-N 2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one;trihydrochloride Chemical compound Cl.Cl.Cl.C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCSCC1=NC=CC=C1Br NYDBUAOXTSYPNN-UHFFFAOYSA-N 0.000 description 1
- BZGIWKRMWCEQGJ-UHFFFAOYSA-N 2-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethylamino]-6-methyl-5-(pyridin-3-ylmethyl)-1h-pyrimidin-4-one Chemical compound N1C(=O)C(CC=2C=NC=CC=2)=C(C)N=C1NCCSCC1=NC=CC=C1Br BZGIWKRMWCEQGJ-UHFFFAOYSA-N 0.000 description 1
- ATAQPWJXJCSDKK-UHFFFAOYSA-N 2-[2-[(3-chloropyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound ClC1=CC=CN=C1CSCCNC(NC1=O)=NC=C1CC1=CC=CN=C1 ATAQPWJXJCSDKK-UHFFFAOYSA-N 0.000 description 1
- GHRFXUKCPYWANF-UHFFFAOYSA-N 2-[2-[(3-iodopyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound IC1=CC=CN=C1CSCCNC(NC1=O)=NC=C1CC1=CC=CN=C1 GHRFXUKCPYWANF-UHFFFAOYSA-N 0.000 description 1
- TWKXVRABHPECFZ-UHFFFAOYSA-N 2-[2-[(4-methylpyridin-2-yl)methylsulfanyl]ethylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound CC1=CC=NC(CSCCNC=2NC(=O)C(CC=3C=NC=CC=3)=CN=2)=C1 TWKXVRABHPECFZ-UHFFFAOYSA-N 0.000 description 1
- BYVSUZHWCBCAOR-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(pyridin-2-ylmethyl)-1h-pyrimidin-6-one;trihydrochloride Chemical compound Cl.Cl.Cl.N1C=NC(CSCCNC=2NC(=O)C(CC=3N=CC=CC=3)=CN=2)=C1C BYVSUZHWCBCAOR-UHFFFAOYSA-N 0.000 description 1
- RJUVKVYJGWHKDA-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(pyridin-4-ylmethyl)-1h-pyrimidin-6-one;trihydrochloride Chemical compound Cl.Cl.Cl.N1C=NC(CSCCNC=2NC(=O)C(CC=3C=CN=CC=3)=CN=2)=C1C RJUVKVYJGWHKDA-UHFFFAOYSA-N 0.000 description 1
- CQGZSYJKAVWBDQ-UHFFFAOYSA-N 2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(thiophen-2-ylmethyl)-1h-pyrimidin-6-one;dihydrochloride Chemical compound Cl.Cl.N1C=NC(CSCCNC=2NC(=O)C(CC=3SC=CC=3)=CN=2)=C1C CQGZSYJKAVWBDQ-UHFFFAOYSA-N 0.000 description 1
- HQPGNVZPWILKRA-UHFFFAOYSA-N 2-[4-(3-aminopyridin-2-yl)butylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound NC1=CC=CN=C1CCCCNC(NC1=O)=NC=C1CC1=CC=CN=C1 HQPGNVZPWILKRA-UHFFFAOYSA-N 0.000 description 1
- NPTIJBQFPCNGNO-UHFFFAOYSA-N 2-[4-(3-chloropyridin-2-yl)butylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound ClC1=CC=CN=C1CCCCNC(NC1=O)=NC=C1CC1=CC=CN=C1 NPTIJBQFPCNGNO-UHFFFAOYSA-N 0.000 description 1
- OOZKKACAURYSLL-UHFFFAOYSA-N 2-[4-(3-chloropyridin-2-yl)butylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCCCC1=NC=CC=C1Cl OOZKKACAURYSLL-UHFFFAOYSA-N 0.000 description 1
- VLZBXOBWRFSHPA-UHFFFAOYSA-N 2-[4-(3-ethoxypyridin-2-yl)butylamino]-5-(pyridin-3-ylmethyl)-1H-pyrimidin-6-one Chemical compound C(C)OC=1C(=NC=CC=1)CCCCNC1=NC=C(C(N1)=O)CC=1C=NC=CC=1 VLZBXOBWRFSHPA-UHFFFAOYSA-N 0.000 description 1
- VZYKJBUUAXGMSD-UHFFFAOYSA-N 2-[4-(3-ethoxypyridin-2-yl)butylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound CCOC1=CC=CN=C1CCCCNC(NC1=O)=NC=C1CC1=CC=C(C)N=C1 VZYKJBUUAXGMSD-UHFFFAOYSA-N 0.000 description 1
- ITPHZQWXVBIHSZ-UHFFFAOYSA-N 2-[4-(3-methoxypyridin-2-yl)butylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound COC1=CC=CN=C1CCCCNC(NC1=O)=NC=C1CC1=CC=CN=C1 ITPHZQWXVBIHSZ-UHFFFAOYSA-N 0.000 description 1
- OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 1
- UUOLETYDNTVQDY-UHFFFAOYSA-N 2-chloro-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1Cl UUOLETYDNTVQDY-UHFFFAOYSA-N 0.000 description 1
- BYVPJDZJIHOUHA-UHFFFAOYSA-N 2-chloro-5,6-dimethylpyridine-3-carbonitrile Chemical compound CC1=CC(C#N)=C(Cl)N=C1C BYVPJDZJIHOUHA-UHFFFAOYSA-N 0.000 description 1
- QRXBTPFMCTXCRD-UHFFFAOYSA-N 2-chloropyridine-4-carbonitrile Chemical compound ClC1=CC(C#N)=CC=N1 QRXBTPFMCTXCRD-UHFFFAOYSA-N 0.000 description 1
- PIFFMIDNNWOQLK-UHFFFAOYSA-N 2-methoxypyridine-3-carbaldehyde Chemical compound COC1=NC=CC=C1C=O PIFFMIDNNWOQLK-UHFFFAOYSA-N 0.000 description 1
- LACWMGLGCJCOFL-UHFFFAOYSA-N 2-methylsulfanyl-5-(quinolin-3-ylmethyl)-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CN=C(C=CC=C2)C2=C1 LACWMGLGCJCOFL-UHFFFAOYSA-N 0.000 description 1
- NMTOPMJVHPNXSD-UHFFFAOYSA-N 2-quinolin-3-ylprop-2-enoic acid Chemical compound C1=CC=CC2=CC(C(=C)C(=O)O)=CN=C21 NMTOPMJVHPNXSD-UHFFFAOYSA-N 0.000 description 1
- HGINADPHJQTSKN-UHFFFAOYSA-M 3-ethoxy-3-oxopropanoate Chemical compound CCOC(=O)CC([O-])=O HGINADPHJQTSKN-UHFFFAOYSA-M 0.000 description 1
- ZLDMYZSLEMYMLL-UHFFFAOYSA-N 3-pyridin-3-ylpropyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OCCCC1=CC=CN=C1 ZLDMYZSLEMYMLL-UHFFFAOYSA-N 0.000 description 1
- WSXGQYDHJZKQQB-UHFFFAOYSA-N 3-pyridin-4-ylpropanoic acid Chemical compound OC(=O)CCC1=CC=NC=C1 WSXGQYDHJZKQQB-UHFFFAOYSA-N 0.000 description 1
- PDVKRIXEUOTSJQ-UHFFFAOYSA-N 3-quinolin-3-ylpropanoic acid Chemical compound C1=CC=CC2=CC(CCC(=O)O)=CN=C21 PDVKRIXEUOTSJQ-UHFFFAOYSA-N 0.000 description 1
- DYBCZGAECZNGOJ-UHFFFAOYSA-N 4-(3-aminopyridin-2-yl)butanenitrile Chemical compound NC1=CC=CN=C1CCCC#N DYBCZGAECZNGOJ-UHFFFAOYSA-N 0.000 description 1
- AISUFNDOCWBLFH-UHFFFAOYSA-N 4-(3-nitropyridin-2-yl)butanenitrile;hydrochloride Chemical compound Cl.[O-][N+](=O)C1=CC=CN=C1CCCC#N AISUFNDOCWBLFH-UHFFFAOYSA-N 0.000 description 1
- WDPZKUGVOPMWLW-UHFFFAOYSA-N 4-methyl-5-(pyridin-3-ylmethyl)-2-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethylamino]-1H-pyrimidin-6-one Chemical compound N=1C(=O)C(CC=2C=NC=CC=2)=C(C)NC=1NCCSCC1=NC=CS1 WDPZKUGVOPMWLW-UHFFFAOYSA-N 0.000 description 1
- BUGNNHLZTBPABI-UHFFFAOYSA-N 5,6-dimethyl-2-oxo-1h-pyridine-3-carbonitrile Chemical compound CC=1C=C(C#N)C(=O)NC=1C BUGNNHLZTBPABI-UHFFFAOYSA-N 0.000 description 1
- VKXZKGRPEBAWBW-UHFFFAOYSA-N 5-(pyridin-3-ylmethyl)-2-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethylamino]-1h-pyrimidin-6-one Chemical compound N=1C=C(CC=2C=NC=CC=2)C(=O)NC=1NCCSCC1=NC=CS1 VKXZKGRPEBAWBW-UHFFFAOYSA-N 0.000 description 1
- KXEBRCRTSDYTFG-UHFFFAOYSA-N 5-(pyridin-4-ylmethyl)-2-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethylamino]-1H-pyrimidin-6-one trihydrochloride Chemical compound Cl.Cl.Cl.N=1C=C(CC=2C=CN=CC=2)C(=O)NC=1NCCSCC1=NC=CS1 KXEBRCRTSDYTFG-UHFFFAOYSA-N 0.000 description 1
- PEECAXUIEQWNMW-UHFFFAOYSA-N 5-(pyridin-4-ylmethyl)-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound O=C1NC(=S)NC=C1CC1=CC=NC=C1 PEECAXUIEQWNMW-UHFFFAOYSA-N 0.000 description 1
- VLJWPLQUEKZQPD-UHFFFAOYSA-N 5-[(2-methoxypyridin-4-yl)methyl]-2-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethylamino]-1h-pyrimidin-6-one Chemical compound C1=NC(OC)=CC(CC=2C(NC(NCCSCC=3SC=CN=3)=NC=2)=O)=C1 VLJWPLQUEKZQPD-UHFFFAOYSA-N 0.000 description 1
- AMGNSOJDRCRSKJ-UHFFFAOYSA-N 5-[(2-methoxypyridin-4-yl)methyl]-2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-1h-pyrimidin-6-one Chemical compound C1=NC(OC)=CC(CC=2C(NC(NCCSCC3=C(NC=N3)C)=NC=2)=O)=C1 AMGNSOJDRCRSKJ-UHFFFAOYSA-N 0.000 description 1
- LSXVIWRCROXVAH-UHFFFAOYSA-N 5-[(2-methoxypyridin-4-yl)methyl]-2-methylsulfanyl-1H-pyrimidin-6-one Chemical compound COC1=NC=CC(=C1)CC=1C(NC(=NC=1)SC)=O LSXVIWRCROXVAH-UHFFFAOYSA-N 0.000 description 1
- XQJIBQMPOYWNDZ-UHFFFAOYSA-N 5-[(5,6-dimethylpyridin-3-yl)methyl]-2-methylsulfanyl-1H-pyrimidin-6-one Chemical compound CC=1C=C(C=NC=1C)CC=1C(NC(=NC=1)SC)=O XQJIBQMPOYWNDZ-UHFFFAOYSA-N 0.000 description 1
- LAMWNDJMJLZNMI-UHFFFAOYSA-N 5-[(6-methoxypyridin-3-yl)methyl]-2-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethylamino]-1h-pyrimidin-6-one Chemical compound C1=NC(OC)=CC=C1CC(C(N1)=O)=CN=C1NCCSCC1=NC=CS1 LAMWNDJMJLZNMI-UHFFFAOYSA-N 0.000 description 1
- VXAISYKQFCWPBO-UHFFFAOYSA-N 5-[(6-methylpyridin-3-yl)methyl]-2-(4-pyridin-2-ylbutylamino)-1h-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCCCC1=CC=CC=N1 VXAISYKQFCWPBO-UHFFFAOYSA-N 0.000 description 1
- AXNSHYDBYJWPHT-UHFFFAOYSA-N 5-[(6-methylpyridin-3-yl)methyl]-2-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethylamino]-1h-pyrimidin-6-one;trihydrochloride Chemical compound Cl.Cl.Cl.C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCSCC1=NC=CS1 AXNSHYDBYJWPHT-UHFFFAOYSA-N 0.000 description 1
- FEQKZDDVINUMPR-UHFFFAOYSA-N 5-[(6-methylpyridin-3-yl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound N1C(SC)=NC(=O)C(CC=2C=NC(C)=CC=2)=C1 FEQKZDDVINUMPR-UHFFFAOYSA-N 0.000 description 1
- IBRVMLVSNYQCGL-UHFFFAOYSA-N 5-[(6-methylpyridin-3-yl)methyl]-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound C1=NC(C)=CC=C1CC1=CNC(=S)NC1=O IBRVMLVSNYQCGL-UHFFFAOYSA-N 0.000 description 1
- DFPYAQAFVHRSAG-UHFFFAOYSA-N 6-methoxypyridine-3-carbonitrile Chemical compound COC1=CC=C(C#N)C=N1 DFPYAQAFVHRSAG-UHFFFAOYSA-N 0.000 description 1
- DYVJHVVJFZYKRB-UHFFFAOYSA-N 6-methyl-2-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethylamino]-5-(pyridin-3-ylmethyl)-1h-pyrimidin-4-one Chemical compound N1C=NC(CSCCNC=2NC(C)=C(CC=3C=NC=CC=3)C(=O)N=2)=C1C DYVJHVVJFZYKRB-UHFFFAOYSA-N 0.000 description 1
- XICAWPWMEAHQIE-UHFFFAOYSA-N 6-methyl-5-(pyridin-3-ylmethyl)-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound N1C(=S)NC(=O)C(CC=2C=NC=CC=2)=C1C XICAWPWMEAHQIE-UHFFFAOYSA-N 0.000 description 1
- AHISYUZBWDSPQL-UHFFFAOYSA-N 6-methylpyridine-2-carbaldehyde Chemical compound CC1=CC=CC(C=O)=N1 AHISYUZBWDSPQL-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- GRESEHVSJAAWFF-UHFFFAOYSA-N Cl.Cl.Cl.CC1=C(N=CN1)CSCCNC1=NC=C(C(N1)=O)CC=1C=NC(=CC1)OC Chemical compound Cl.Cl.Cl.CC1=C(N=CN1)CSCCNC1=NC=C(C(N1)=O)CC=1C=NC(=CC1)OC GRESEHVSJAAWFF-UHFFFAOYSA-N 0.000 description 1
- UGSDTSAWKZGYGP-UHFFFAOYSA-N Cl.Cl.Cl.CC1=C(N=CN1)CSCCNC1=NC=C(C(N1)=O)CC=1C=NC2=CC=CC=C2C1 Chemical compound Cl.Cl.Cl.CC1=C(N=CN1)CSCCNC1=NC=C(C(N1)=O)CC=1C=NC2=CC=CC=C2C1 UGSDTSAWKZGYGP-UHFFFAOYSA-N 0.000 description 1
- NUWCQCVJLQSZFN-UHFFFAOYSA-N Cl.Cl.Cl.O=C1N=CC=CN1 Chemical compound Cl.Cl.Cl.O=C1N=CC=CN1 NUWCQCVJLQSZFN-UHFFFAOYSA-N 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000000543 Histamine Receptors Human genes 0.000 description 1
- 108010002059 Histamine Receptors Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OLKLIJWKYDLDOD-UHFFFAOYSA-N N=C1C(CC2=CC=CN=C2)=COC(NCCCCC2=NC=CC=C2Br)=C1 Chemical compound N=C1C(CC2=CC=CN=C2)=COC(NCCCCC2=NC=CC=C2Br)=C1 OLKLIJWKYDLDOD-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 108010079943 Pentagastrin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001061127 Thione Species 0.000 description 1
- CDXSJGDDABYYJV-UHFFFAOYSA-N acetic acid;ethanol Chemical compound CCO.CC(O)=O CDXSJGDDABYYJV-UHFFFAOYSA-N 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000006309 butyl amino group Chemical group 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 description 1
- 229940097265 cysteamine hydrochloride Drugs 0.000 description 1
- YJJLOESDBPRZIP-UHFFFAOYSA-N diethyl 2-(2-cyanoethyl)propanedioate Chemical compound CCOC(=O)C(CCC#N)C(=O)OCC YJJLOESDBPRZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- KGLRWOREQVWOBQ-UHFFFAOYSA-N ethyl 2-[(5,6-dimethylpyridin-3-yl)methyl]-3-oxopropanoate Chemical compound CCOC(=O)C(C=O)CC1=CN=C(C)C(C)=C1 KGLRWOREQVWOBQ-UHFFFAOYSA-N 0.000 description 1
- ZURUNHBLOGXHCQ-UHFFFAOYSA-N ethyl 3-(5,6-dimethylpyridin-3-yl)propanoate Chemical compound CCOC(=O)CCC1=CN=C(C)C(C)=C1 ZURUNHBLOGXHCQ-UHFFFAOYSA-N 0.000 description 1
- IQXXDFIZZHXWBM-UHFFFAOYSA-N ethyl 3-(6-methoxypyridin-3-yl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(OC)N=C1 IQXXDFIZZHXWBM-UHFFFAOYSA-N 0.000 description 1
- AQTUCCJYJLYXFR-UHFFFAOYSA-N ethyl 3-quinolin-3-ylprop-2-enoate Chemical compound C1=CC=CC2=CC(C=CC(=O)OCC)=CN=C21 AQTUCCJYJLYXFR-UHFFFAOYSA-N 0.000 description 1
- LTOOPRHOYJCDRC-UHFFFAOYSA-N ethyl 3-quinolin-3-ylpropanoate Chemical compound C1=CC=CC2=CC(CCC(=O)OCC)=CN=C21 LTOOPRHOYJCDRC-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940041476 lactose 100 mg Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- LWHYKTAISUZRAD-UHFFFAOYSA-L palladium(2+);carbonate Chemical compound [Pd+2].[O-]C([O-])=O LWHYKTAISUZRAD-UHFFFAOYSA-L 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- ANRIQLNBZQLTFV-DZUOILHNSA-N pentagastrin Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1[C]2C=CC=CC2=NC=1)NC(=O)CCNC(=O)OC(C)(C)C)CCSC)C(N)=O)C1=CC=CC=C1 ANRIQLNBZQLTFV-DZUOILHNSA-N 0.000 description 1
- 229960000444 pentagastrin Drugs 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5300175 | 1975-12-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5283388A JPS5283388A (en) | 1977-07-12 |
| JPS6129355B2 true JPS6129355B2 (pt) | 1986-07-05 |
Family
ID=10466233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15611076A Granted JPS5283388A (en) | 1975-12-29 | 1976-12-23 | Heterocyclic compounds |
Country Status (37)
| Country | Link |
|---|---|
| JP (1) | JPS5283388A (pt) |
| AR (1) | AR222290A1 (pt) |
| AT (1) | AT360024B (pt) |
| AU (1) | AU508123B2 (pt) |
| BE (1) | BE849810A (pt) |
| BG (1) | BG29722A3 (pt) |
| CA (1) | CA1073458A (pt) |
| CH (1) | CH631981A5 (pt) |
| CS (1) | CS203995B2 (pt) |
| DD (1) | DD128588A5 (pt) |
| DE (1) | DE2658267A1 (pt) |
| DK (1) | DK587076A (pt) |
| EG (1) | EG12439A (pt) |
| ES (1) | ES454656A1 (pt) |
| FI (1) | FI62668C (pt) |
| FR (1) | FR2336935A1 (pt) |
| GR (1) | GR62441B (pt) |
| HU (1) | HU175171B (pt) |
| IE (1) | IE45082B1 (pt) |
| IL (1) | IL51040A (pt) |
| IT (2) | IT1124740B (pt) |
| LU (1) | LU76481A1 (pt) |
| MW (1) | MW5076A1 (pt) |
| MX (1) | MX5119E (pt) |
| NL (1) | NL7614538A (pt) |
| NO (1) | NO146396C (pt) |
| NZ (1) | NZ182759A (pt) |
| OA (1) | OA05526A (pt) |
| PH (1) | PH14723A (pt) |
| PL (1) | PL104376B1 (pt) |
| PT (1) | PT65949B (pt) |
| RO (1) | RO72475A (pt) |
| SE (1) | SE431544B (pt) |
| SU (1) | SU791235A3 (pt) |
| YU (1) | YU311676A (pt) |
| ZA (1) | ZA767198B (pt) |
| ZM (1) | ZM14376A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ186511A (en) | 1977-03-19 | 1980-11-14 | Smith Kline French Lab | 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones |
| IL56265A (en) * | 1977-12-28 | 1982-08-31 | Om Lab Sa | Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor |
| US4539207A (en) * | 1978-02-13 | 1985-09-03 | Smith Kline & French Laboratories Limited | Pyrimidine compounds |
| IN151188B (pt) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
| PH16240A (en) * | 1978-04-11 | 1983-08-11 | Smith Kline French Lab | Process for making histamine antagonist |
| ZA792607B (en) * | 1978-05-30 | 1980-07-30 | Smith Kline French Lab | Nitro compounds |
| PT69886A (en) * | 1978-07-15 | 1979-08-01 | Smith Kline French Lab | Process for preparing isoureas and isothioureas |
| US4309435A (en) | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| US4374836A (en) | 1978-10-16 | 1983-02-22 | Imperial Chemical Industries Ltd. | Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them |
| US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
| US4521418A (en) * | 1979-02-21 | 1985-06-04 | Smith Kline & French Laboratories Limited | Guanidinothiazolyl derivatives |
| US4255428A (en) | 1979-03-24 | 1981-03-10 | Smith Kline & French Laboratories Limited | 5-(Hydroxypyridylalkyl)-4-pyrimidones |
| JPS55133379A (en) * | 1979-04-05 | 1980-10-17 | Smith Kline French Lab | Pyrimidone compound |
| EP0017680B1 (en) * | 1979-04-11 | 1982-04-21 | Smith Kline & French Laboratories Limited | Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them |
| JPS55145683A (en) * | 1979-04-26 | 1980-11-13 | Smith Kline French Lab | Pyrimidone derivative |
| CA1155842A (en) * | 1980-03-29 | 1983-10-25 | Thomas H. Brown | Compounds |
| ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
| IE53068B1 (en) * | 1981-06-15 | 1988-05-25 | Merck & Co Inc | Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors |
| PT75074B (en) * | 1981-06-27 | 1986-02-26 | Smith Kline French Lab | Process for preparing certain pyrimidone derivatives and compositions containing them |
| US6417366B2 (en) * | 1999-06-24 | 2002-07-09 | Abbott Laboratories | Preparation of quinoline-substituted carbonate and carbamate derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
| IN146736B (pt) * | 1975-10-02 | 1979-08-25 | Smith Kline French Lab |
-
1976
- 1976-11-22 MW MW50/76A patent/MW5076A1/xx unknown
- 1976-11-29 NZ NZ182759A patent/NZ182759A/xx unknown
- 1976-12-02 ZA ZA767198A patent/ZA767198B/xx unknown
- 1976-12-02 IL IL51040A patent/IL51040A/xx unknown
- 1976-12-08 CA CA267,385A patent/CA1073458A/en not_active Expired
- 1976-12-09 IT IT30235/76A patent/IT1124740B/it active
- 1976-12-10 PT PT65949A patent/PT65949B/pt unknown
- 1976-12-17 PH PH19265A patent/PH14723A/en unknown
- 1976-12-17 ZM ZM143/76A patent/ZM14376A1/xx unknown
- 1976-12-21 FI FI763664A patent/FI62668C/fi not_active IP Right Cessation
- 1976-12-22 YU YU03116/76A patent/YU311676A/xx unknown
- 1976-12-22 IE IE2814/76A patent/IE45082B1/en unknown
- 1976-12-22 DE DE19762658267 patent/DE2658267A1/de not_active Ceased
- 1976-12-22 GR GR52462A patent/GR62441B/el unknown
- 1976-12-23 JP JP15611076A patent/JPS5283388A/ja active Granted
- 1976-12-23 BE BE173597A patent/BE849810A/xx not_active IP Right Cessation
- 1976-12-23 CH CH1627876A patent/CH631981A5/de not_active IP Right Cessation
- 1976-12-23 AT AT960876A patent/AT360024B/de not_active IP Right Cessation
- 1976-12-27 RO RO7688851A patent/RO72475A/ro unknown
- 1976-12-28 SE SE7614620A patent/SE431544B/xx not_active IP Right Cessation
- 1976-12-28 HU HU76SI1556A patent/HU175171B/hu unknown
- 1976-12-28 PL PL1976194772A patent/PL104376B1/pl unknown
- 1976-12-28 NO NO764370A patent/NO146396C/no unknown
- 1976-12-28 BG BG035033A patent/BG29722A3/xx unknown
- 1976-12-28 EG EG803/76A patent/EG12439A/xx active
- 1976-12-28 LU LU76481A patent/LU76481A1/xx unknown
- 1976-12-29 NL NL7614538A patent/NL7614538A/xx not_active Application Discontinuation
- 1976-12-29 DD DD7600196703A patent/DD128588A5/xx unknown
- 1976-12-29 AR AR266049A patent/AR222290A1/es active
- 1976-12-29 CS CS768760A patent/CS203995B2/cs unknown
- 1976-12-29 FR FR7639465A patent/FR2336935A1/fr active Granted
- 1976-12-29 SU SU762434655A patent/SU791235A3/ru active
- 1976-12-29 DK DK587076A patent/DK587076A/da not_active Application Discontinuation
- 1976-12-29 OA OA56028A patent/OA05526A/xx unknown
- 1976-12-29 ES ES454656A patent/ES454656A1/es not_active Expired
- 1976-12-30 AU AU20976/76A patent/AU508123B2/en not_active Expired
-
1977
- 1977-01-03 MX MX775273U patent/MX5119E/es unknown
-
1979
- 1979-01-05 IT IT7919107A patent/IT7919107A0/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6129355B2 (pt) | ||
| EP0003677B1 (en) | Pyrimidones, processes for their preparation and pharmaceutical compositions containing them | |
| US4154834A (en) | Substituted isocytosines having histamine H2 -antagonist activity | |
| DE69223734T2 (de) | Kondensierte Pyrimidinderivate und deren Verwendung als Angiotensin-II-Antagonisten | |
| US4216318A (en) | Heterocyclic alkyl 4-pyrimidones | |
| JPS5855145B2 (ja) | ガンチツソフクソカンカゴウブツ ノ セイゾウホウ | |
| JPS6328069B2 (pt) | ||
| US4659725A (en) | 3-(2-pyridylaminoalkylamino)cyclobutenediones and pyridones useful as histamine H1 -antagonists | |
| EP0015138B1 (en) | Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| EP0068833A2 (en) | Pyrimidinone derivatives and pharmaceutical compositions containing them | |
| EP0244201B1 (en) | 3-hydroxypyridines | |
| US4639519A (en) | 2-substituted alkylaminopyrimidones useful as H2 -antagonists and antiinflamatory agents | |
| EP0039989B1 (en) | Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| US4185103A (en) | Pharmacologically active triazinones | |
| US4419362A (en) | Imidazalylalkylthioimidazoles | |
| US4539207A (en) | Pyrimidine compounds | |
| JPS58154579A (ja) | ピリミドン誘導体 | |
| EP0083186B1 (en) | Thiazole derivatives as h2-receptor antagonists | |
| US4468399A (en) | 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones | |
| GB2038825A (en) | Heterocyclic compounds substituted by heterocyclyl-alkylthia groups | |
| EP0198633A2 (en) | Pyridine derivatives | |
| KR830000313B1 (ko) | 피리미돈의 제조방법 | |
| GB1582527A (en) | Pyrimidone and thiopyrimidone derivatives | |
| NZ206853A (en) | Pyridine-pyrimidinone derivatives and pharmaceutical compositions thereof | |
| IE47815B1 (en) | Pyrimidone derivatives,process for preparing them and pharmaceutical compositions containing them |